- Did you mean
- clinical materials as topics
Search results - 43 results
Substandard and falsified ivermectin tablets obtained for self-medication during the COVID-19 pandemic as a source of potential harm.
One of the candidate antiviral medicines tested was ivermectin. Although several health authorities warned the public against the use of this medicine outside clinical trials, the drug was widely used ...
Oncolytic Viruses: An Inventory of Shedding Data from Clinical Trials and Elements for the Environmental Risk Assessment.
Publication Type: Peer reviewed scientific article Authors: Onnockx, Sheela; Aline Baldo; Katia Pauwels Source: Vaccines (Basel), Volume 11, Issue 9 (2023) Keywords: biosafety cancer Clinical trials ...
Immunogenicity and one-year boostability of a 3-dose intramuscular rabies pre-exposure prophylaxis schedule in adults receiving immunosuppressive monotherapy: a prospective single-Centre clinical trial.
boostability, defined as the proportion of patients with a neutralizing antibody titre of ≥ 0.5 IU /mL at Month 12 + 7 days. Secondary outcomes were geometric mean titres and factors associated with the ...
Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis.
Mikstacki; José-Artur Paiva; Cecilia Pereyra; Jordi Rello; Jean-Francois Timsit; Vogelaers, Dirk; Blot, Stijn; Abdominal Sepsis Study (AbSeS) group and the Trials Group of the European Society of Intensive ...
Epidemiology and age-related mortality in critically ill patients with intra-abdominal infection or sepsis: an international cohort study.
overall disease severity further compromised survival. As all of these factors are non-modifiable, it remains unclear how to improve outcomes. Health Topics: Health and disease monitoring Surveillance de ...
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.
healthy humans. Next, we summarize data from early trials of SARS- COV-2 mRNA vaccination in patients with secondary or primary immunodeficiency. These early clinical trials identified common predictors of ...
Unravelling data for rapid evidence-based response to COVID-19: a summary of the unCoVer protocol
potential strategies against COVID-19, as well as epidemiological patterns. These analyses will complement evidence from efficacy/safety clinical trials, where vulnerable, more complex/heterogeneous ...
Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.
publicly available website of the Belgian health authorities (Sciensano). TRIAL REGISTRATION NUMBER: NCT04779424. Health Topics: Health and disease monitoring Surveillance de la santé et des maladies ...
Unravelling data for rapid evidence-based response to COVID-19: a summary of the unCoVer protocol.
effectiveness of treatments, and potential strategies against COVID-19, as well as epidemiological patterns. These analyses will complement evidence from efficacy/safety clinical trials, where vulnerable, more ...
Conceptual causal framework to assess the effect of SARS-CoV-2 variants on COVID-19 disease severity among hospitalized patients
data requirements, and it underlines important limitations, such as unmeasured confounders or selection bias, inherent to repurposing existing routine COVID-19 data registries. TRIAL REGISTRATION: Each ...